Sequenom (SQNM) and Xenomics Announce Exclusive Licensing Agreement for Prenatal Diagnostic Products
Tweet Send to a Friend
Sequenom, Inc. (NASDAQ: SQNM) today announced that it has licensed from Xenomics, Inc. exclusive rights to patents (U.S. Patents 6,251,638 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
